| P2093 | author name string | Christer Larsson | |
| | Yvonne Ceder | |
| | Chandrani Achari | |
| | Sofia Winslow | |
| P2860 | cites work | miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer | Q21133750 |
| | Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells | Q24329077 |
| | MicroRNAs: target recognition and regulatory functions | Q24609584 |
| | miR-34a repression of SIRT1 regulates apoptosis | Q24652720 |
| | A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene | Q39978280 |
| | Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest | Q39992760 |
| | p53-mediated activation of miRNA34 candidate tumor-suppressor genes. | Q40102003 |
| | Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation | Q43251963 |
| | Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer | Q46250990 |
| | Chromosomal alterations associated with the transition from in situ to invasive breast cancer | Q46486645 |
| | Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. | Q46714700 |
| | Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest | Q48078984 |
| | Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. | Q53259995 |
| | Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions | Q72033722 |
| | Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer | Q73299575 |
| | MicroRNAs in cancer | Q86065522 |
| | miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions | Q95780206 |
| | Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 |
| | MicroRNA targets in Drosophila | Q24806738 |
| | Combinatorial microRNA target predictions | Q27860510 |
| | Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 |
| | Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 |
| | The diverse functions of microRNAs in animal development and disease | Q28266193 |
| | MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells | Q28287986 |
| | Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer | Q28291502 |
| | A microRNA component of the p53 tumour suppressor network | Q28305330 |
| | Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling | Q28477912 |
| | p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication | Q28587920 |
| | microRNA-34a promotes DNA damage and mitotic catastrophe. | Q30409530 |
| | MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes | Q30434616 |
| | miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme | Q33856653 |
| | PKCalpha expression is a marker for breast cancer aggressiveness | Q33864132 |
| | miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes | Q34186822 |
| | MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype | Q34212221 |
| | MicroRNA-34c enhances murine male germ cell apoptosis through targeting ATF1. | Q34221689 |
| | MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis | Q34278292 |
| | miR-34 - a microRNA replacement therapy is headed to the clinic | Q34640230 |
| | Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. | Q34783833 |
| | MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer | Q34785711 |
| | MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells | Q35643732 |
| | miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. | Q35889599 |
| | Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. | Q36297343 |
| | A microRNA DNA methylation signature for human cancer metastasis | Q36861111 |
| | The quest for the 1p36 tumor suppressor | Q37138877 |
| | DIANA-microT web server: elucidating microRNA functions through target prediction | Q37245804 |
| | 1p36 tumor suppression--a matter of dosage? | Q38061568 |
| | MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth | Q38298486 |
| | The tumour suppressor miR-34c targets MET in prostate cancer cells | Q39114252 |
| | MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. | Q39273521 |
| | MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. | Q39343253 |
| | MicroRNAs impair MET-mediated invasive growth | Q39906019 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 538 | |
| P577 | publication date | 2014-07-26 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells | |
| P478 | volume | 14 | |